EcoDrugPlus

Trace Amine Associated Receptor 1

Ensembl ID : ENSOJAG00000006158
Gene Symbol: TAAR1
1 Cross references
378 Possible Orthologues:

Transforming Growth Factor, Beta Receptor 1 B

Ensembl ID : ENSOJAG00000023021
Gene Symbol: TGFBR1B
1 Cross references
204 Possible Orthologues:

Transient Receptor Potential Cation Channel, Subfamily A, Member 1b

Ensembl ID : ENSOJAG00000019249
Gene Symbol: TRPA1B
1 Cross references
200 Possible Orthologues:

Tryptophan Hydroxylase 1 (Tryptophan 5-Monooxygenase) A

Ensembl ID : ENSOJAG00000001909
Gene Symbol: TPH1A
1 Cross references
207 Possible Orthologues:

Tryptophan Hydroxylase 1b

Ensembl ID : ENSOJAG00000009345
Gene Symbol: TPH1B
1 Cross references
176 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSOJAG00000021745
Gene Symbol: TUBA4A
1 Cross references
169 Possible Orthologues:

Tubulin, Beta 2a Class Iia

Ensembl ID : ENSOJAG00000012588
Gene Symbol: TUBB2
1 Cross references
305 Possible Orthologues:

Tubulin, Beta 5

Ensembl ID : ENSOJAG00000015383
Gene Symbol: TUBB5
1 Cross references
160 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSOJAG00000008784
Gene Symbol: TYR
1 Cross references
198 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSOJAG00000008238
Gene Symbol: TYR
1 Cross references
202 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSOJAG00000000427
Gene Symbol: TH
1 Cross references
187 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSOJAG00000020936
Gene Symbol: TYK2
1 Cross references
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).